Vizuro and DCB Join Forces to Revolutionize Drug Discovery and Precision Medicine with Causal Generative AI

Vizuro LLC, a leading innovator in multimodal causal AI technology, and the Development Center for Biotechnology (DCB) announced the signing of a Memorandum of Understanding (MOU) BOSTON, Dec. 26, 2024 /PRNewswire-PRWeb/ -- Vizuro LLC, a leading innovator in multimodal causal AI...